| Literature DB >> 35295398 |
Wenjun Bian1, Xiaocong Zhang1, Yunying Dong2.
Abstract
Test anxiety is a widespread and primarily detrimental emotion in learning and achievement settings. This research aimed to explore the autonomic nervous system (ANS) response patterns of test-anxious individuals in response to evaluative stress. By presenting a standard interview task, an evaluative scenario was effectively induced. Heart rate variability (HRV), a biomarker that can accurately reflect the ANS activity, was used to reflect the physiological responses of 48 high test-anxious subjects and 49 low test-anxious subjects. Results indicate that: (1) both groups show a significantly increased emotional arousal in the evaluative scenario; (2) high test-anxious individuals show a significantly decreased emotional pleasantness in the evaluative scenario, whereas low test-anxious individuals show no significant changes; (3) both groups show a significantly increased low-frequency HRV; (4) high test-anxious individuals show a significantly decreased high-frequency HRV and root mean square of successive heartbeat interval differences (RMSSD), whereas low test-anxious individuals remain stable. These findings suggest that high test-anxious individuals display an increased sympathetic nervous system (SNS) activity and a decreased parasympathetic nervous system (PNS) activity in response to evaluative stress, while low-anxious individuals display an increased SNS activity and a stable PNS activity in response to evaluative stress.Entities:
Keywords: HRV; evaluative stress; parasympathetic nerve; sympathetic nerve; test anxiety
Year: 2022 PMID: 35295398 PMCID: PMC8918774 DOI: 10.3389/fpsyg.2022.824406
Source DB: PubMed Journal: Front Psychol ISSN: 1664-1078
FIGURE 1Experimental flow diagram.
Emotional experience and HRV values in three experimental phases (mean ± standard deviation).
| Subjects | Experimental phase | Arousal | Pleasantness | Ln LF | Ln HF | Ln RMSSD |
| LTA ( | Baseline phase | 2.96 ± 1.34 | 5.55 ± 1.26 | 6.42 ± 0.83 | 6.06 ± 0.92 | 3.61 ± 0.73 |
| Stress phase | 5.65 ± 1.42 | 5.47 ± 1.20 | 7.18 ± 0.63 | 6.19 ± 0.93 | 3.69 ± 0.72 | |
| Recovery phase | 3.73 ± 1.57 | 5.45 ± 1.17 | 6.58 ± 0.74 | 6.08 ± 0.87 | 3.62 ± 0.71 | |
| HTA ( | Baseline phase | 3.83 ± 1.55 | 5.40 ± 1.14 | 6.29 ± 0.75 | 6.37 ± 0.83 | 3.77 ± 0.95 |
| Stress phase | 6.73 ± 1.32 | 4.27 ± 1.62 | 6.58 ± 0.73 | 5.79 ± 0.91 | 3.58 ± 1.09 | |
| Recovery phase | 4.33 ± 1.36 | 5.06 ± 1.08 | 6.40 ± 0.60 | 6.34 ± 0.78 | 3.80 ± 0.95 |
FIGURE 2Differences in emotional arousal during three experimental phases of HTA and LTA individuals. *** represents a significant difference between the baseline and stress phase of both groups with p-value < 0.001.
FIGURE 3Differences in emotional pleasantness during three experimental phases of HTA and LTA individuals. *** represents a significant difference between the baseline and stress phase of HTA individuals with p-value < 0.001.
FIGURE 4Differences in Ln LF during three experimental phases of HTA and LTA individuals. *** represents a significant difference between the baseline and stress phase of LTA individuals with p-value < 0.001. * represents a significant difference between the baseline and stress phase of HTA individuals with p-value < 0.05.
FIGURE 5Differences in Ln HF during three experimental phases of HTA and LTA individuals. *** represents a significant difference between the baseline and stress phase of HTA individuals with p-value < 0.001.
FIGURE 6Differences in Ln RMSSD during three experimental phases of HTA and LTA individuals. ** represents a significant difference between the baseline and stress phase of HTA individuals with p-value < 0.01.